ADHD is officially classified as a neurodevelopmental disorder by both major diagnostic systems used worldwide. The American Psychiatric Association’s DSM-5 and the World Health Organization’s ICD-11 place it in the neurodevelopmental category, meaning it originates in early brain development and affects how a person thinks, learns, and regulates behavior across their lifespan. This wasn’t always the case in every system. The previous version of the WHO’s classification (ICD-10) grouped it under behavioral disorders of childhood. The reclassification reflects decades of evidence showing that ADHD stems from measurable differences in brain structure, chemistry, and maturation.
What “Neurodevelopmental” Actually Means
A neurodevelopmental disorder is one that emerges during the brain’s development, typically before or during childhood, and affects cognitive or social functioning. It’s not something you “catch” or develop suddenly in midlife. For ADHD specifically, the DSM-5 requires that several symptoms be present before age 12. This age-of-onset requirement is one of the features that distinguishes neurodevelopmental conditions from psychiatric disorders that tend to appear later, like depression or generalized anxiety.
Other conditions in the same diagnostic category include autism spectrum disorder, intellectual disabilities, and specific learning disorders like dyslexia. These conditions frequently overlap. Between 50 and 70% of people with autism also meet criteria for ADHD, and both conditions share difficulties with attention, working memory, and processing speed.
Brain Differences Behind the Diagnosis
Structural brain imaging has identified consistent differences in people with ADHD. MRI studies show reduced gray matter volume in three regions central to planning, impulse control, and coordination: the frontal cortex, the basal ganglia (a cluster of structures deep in the brain involved in movement and reward), and the cerebellum. There is also evidence of delayed cortical maturation, meaning the outer layer of the brain thickens and thins on a slower timeline than in people without ADHD. This delay is especially pronounced in the prefrontal areas responsible for decision-making and attention.
At the chemical level, two signaling molecules play central roles: dopamine and norepinephrine. These chemicals help relay messages across brain circuits that control executive functions like focusing, planning, and stopping yourself from acting on impulse. In ADHD, signaling through these pathways is less efficient. This is why the most common ADHD medications work by increasing the availability of these molecules in the brain, essentially boosting a signal that’s running too quietly.
Working Memory as a Core Problem
One of the most well-documented cognitive effects of ADHD is impaired working memory, the ability to hold information in your mind and actively use it. Think of it as a mental workspace: you need it to follow multi-step instructions, keep track of a conversation, or do mental math. Research using detailed cognitive testing found that 75 to 81% of children with ADHD showed significant working memory impairments, with effect sizes ranging from large to very large. These deficits correlated directly with both inattentive and hyperactive/impulsive symptom severity.
Interestingly, not all types of memory are equally affected. Basic verbal short-term memory (repeating back a string of numbers, for example) appears to be intact in most children with ADHD. The problem is specific to the active, executive component of memory, the part that requires manipulating and updating information rather than simply holding it. This pattern supports the idea that ADHD is fundamentally a disorder of executive control, not of memory storage.
Genetics and Environmental Factors
ADHD is one of the most heritable psychiatric conditions. Twin studies consistently estimate its heritability at 77 to 88%, meaning the vast majority of variation in who develops ADHD is explained by genetic factors. For comparison, that heritability rate is higher than most other mental health conditions. No single gene causes ADHD. Instead, many common genetic variants each contribute a small amount of risk, and researchers estimate that these variants collectively account for about 22% of the heritability that twin studies detect. The gap suggests that rare genetic variants, gene interactions, and other mechanisms are also at play.
Environmental exposures during pregnancy also influence risk. Prenatal alcohol exposure increases the likelihood of ADHD by about 1.5 times. Maternal smoking during pregnancy raises the risk by roughly 2.6 times. Even secondhand tobacco smoke exposure during pregnancy, without the mother smoking herself, is associated with a modest increase. When a developing fetus is exposed to both secondhand smoke and alcohol, the combined risk is about 1.6 times higher than baseline. These environmental factors don’t override genetics, but they can nudge a developing brain toward the condition, particularly in children who are already genetically predisposed.
How ADHD Changes Over a Lifetime
Because ADHD is neurodevelopmental, it begins in childhood, but it doesn’t necessarily stay the same. About 45 to 85% of children with ADHD remain symptomatic through adolescence, and roughly 50 to 60% continue to experience symptoms into adulthood. A long-term follow-up from the landmark MTA study found that by young adulthood, about half of participants still met symptom criteria while the other half had improved enough to no longer qualify.
The type of symptoms that persist tends to shift. Hyperactivity and impulsivity generally decrease with age. A child who couldn’t stay in their seat may become an adult who feels internally restless but can sit through a meeting. Inattentive symptoms, like difficulty organizing tasks, losing things, and trouble sustaining focus, tend to be more stubborn. Prevalence rates also appear to decline further between young adulthood and middle age, suggesting that some people continue to experience gradual improvement well into their 30s and 40s.
How ADHD Is Diagnosed
Diagnosis requires a specific number of symptoms from two categories: inattention and hyperactivity/impulsivity. Children up to age 16 need at least six symptoms in one or both categories. Adolescents 17 and older and adults need five. The symptoms must have been present for at least six months, must appear in two or more settings (home and work, for instance), and must clearly interfere with functioning. A child who’s fidgety only during one boring class, or an adult who occasionally loses their keys, wouldn’t meet the threshold.
The requirement that symptoms appear across multiple settings is important. It helps distinguish ADHD from situational problems like a stressful home life or a poor classroom fit. Combined with the before-age-12 onset requirement, the diagnostic framework is designed to identify a pattern rooted in neurodevelopment rather than circumstances.